Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Giovanna Guimaraes Lopes Bergamasco, PhD student in Nutrition and Metabolism, University of Alberta

SHOCKING: Why dont glp 1 obesity drugs work for everyone - You Need To See This

Medications like Ozempic and Wegovy, which contain semaglutide — a GLP‑1 receptor agonist that helps regulate blood sugar, appetite and body weight — have become household names and important pillars in obesity management for the medical profession.

Research has shown GLP-1 medications reduce body weight by an average of 15 per cent when used weekly for 68 weeks and combined with lifestyle interventions. This is because semaglutide acts on the brain to increase the feeling of fullness and to decrease appetite.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.